Document is current
Any future updates will be listed below
-
Authors
Miyashita, Mitsuhiro https://orcid.org/0000-0002-7798-1834
Yamasaki, Syudo https://orcid.org/0000-0002-9016-6404
Ando, Shuntaro
Suzuki, Kazuhiro https://orcid.org/0000-0002-0038-4329
Toriumi, Kazuya https://orcid.org/0000-0002-8593-3269
Horiuchi, Yasue https://orcid.org/0000-0003-0597-2514
Yoshikawa, Akane
Imai, Atsushi
Nagase, Yukihiro
Miyano, Yasuhiro
Inoue, Tomoko
Endo, Kaori https://orcid.org/0000-0003-0854-5120
Morimoto, Yuko
Morita, Masaya
Kiyono, Tomoki
Usami, Satoshi
Okazaki, Yuji
Furukawa, Toshiaki A.
Hiraiwa-Hasegawa, Mariko
Itokawa, Masanari
Kasai, Kiyoto https://orcid.org/0000-0002-4443-4535
Nishida, Atsushi
Arai, Makoto https://orcid.org/0000-0003-3400-9815
- License Information
-
More Information
Article History
Received: 7 February 2021
Accepted: 20 July 2021
First Online: 12 August 2021
Competing interests
: M.M. reports grants from the Japan Society for the Promotion of Science (JSPS) during the conduct of the study and others from Kowa Co. Ltd., outside the submitted work. Additionally, M.M. has a patent PCT/JP2008/063803 with royalties paid to Kowa Co. Ltd. S.Y. reports grants from JSPS during the conduct of the study. S.A. reports grants from JSPS during the conduct of the study. A.I. reports personal fees from Otsuka, and Meiji, outside the submitted work. Y.N. reports personal fees from Otsuka, Takeda, MSD, Eisai, Lily, Sumitomo Dainippon Pharma, Pfizer, Meiji, Yoshitomi, Novartis, Janssen, and Lundbeck, outside the submitted work. T.A.F. reports personal fees from Mitsubishi Tanabe Pharma, MSD, and Shionogi and a grant from Mitsubishi Tanabe Pharma, outside the submitted work. Additionally, T.A.F. has a pending patent (2018-177688). M.I. reports other from Mitsubishi Tanabe Pharma, Sumitomo Dainippon Pharma, Pfizer, and CHUGAI, outside the submitted work. Additionally, M.I. has a patent PCT/JP2008/063803 with royalties paid to Kowa Co. Ltd. K.K. reports grants from JSPS from null, during the conduct of the study, personal fees from Daiichi Sankyo, personal fees from Otsuka, personal fees from Meiji Seika Pharma, grants and personal fees from MSD, personal fees from Yoshitomi, grants and personal fees from Astellas, personal fees from Mochida, grants and personal fees from Sumitomo Dainippon Pharma, grants and personal fees from Eisai, personal fees from Fuji-Film RI Pharma, grants from Lily, grants from Takeda, and grants from Mitsubishi Tanabe Pharma, outside the submitted work. A.N. reports grants from JSPS during the conduct of the study. M.A. reports grants from JSPS, grants from the Uehara Memorial Foundation, grants from the Sumitomo Foundation during the conduct of the study, and others from Kowa Co. Ltd., outside the submitted work. Additionally, M.A. has a patent PCT/JP2008/063803 with royalties paid to Kowa Co. Ltd. The other authors declare no competing interests.
